Basal-cell carcinoma
Basal-cell cancer is a very common skin cancer. It is much more common in fair-skinned individuals with a family history of basal-cell cancer and increases in incidence closer to the equator or at higher altitude. There are approximately 800,000 new cases yearly in the United States alone. Up to 30% of Caucasians develop basal-cell carcinomas in their lifetime. In Canada, the most common skin cancer is basal-cell carcinoma (as much as one third of all cancer diagnoses), affecting 1 in 7 individuals over a lifetime.
Basaloid large cell carcinoma of the lung
Bas-LCLC are considered to have a particularly poor prognosis, even compared to other forms of lung cancer. However, not all studies have confirmed this.
Basaloid carcinomas of the lung (like nearly all other recognized subtypes of lung cancer) are highly associated with tobacco smoking. Basaloid architecture in pulmonary carcinomas have been shown to be particularly prevalent in smokers with heavy exposure,
Basaloid forms of lung carcinoma were first described in the peer-reviewed medical literature by Dr. Elisabeth Brambilla and her colleagues in 1992. They were first recognized as distinct clinicopathological variants of both squamous cell and large cell lung cancers in 1999, within the third revision of the World Health Organization lung tumor typing and classification scheme.